Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 31

1.

Enhancing Cognitive Training Through Aerobic Exercise After a First Schizophrenia Episode: Theoretical Conception and Pilot Study.

Nuechterlein KH, Ventura J, McEwen SC, Gretchen-Doorly D, Vinogradov S, Subotnik KL.

Schizophr Bull. 2016 Jul;42 Suppl 1:S44-52. doi: 10.1093/schbul/sbw007.

2.

Decreased Oligodendrocyte and Neuron Number in Anterior Hippocampal Areas and the Entire Hippocampus in Schizophrenia: A Stereological Postmortem Study.

Falkai P, Malchow B, Wetzestein K, Nowastowski V, Bernstein HG, Steiner J, Schneider-Axmann T, Kraus T, Hasan A, Bogerts B, Schmitz C, Schmitt A.

Schizophr Bull. 2016 Jul;42 Suppl 1:S4-S12. doi: 10.1093/schbul/sbv157.

3.

A New Outlook on Mental Illnesses: Glial Involvement Beyond the Glue.

Elsayed M, Magistretti PJ.

Front Cell Neurosci. 2015 Dec 16;9:468. doi: 10.3389/fncel.2015.00468. eCollection 2015. Review.

4.

Developing a Cognitive Training Strategy for First-Episode Schizophrenia: Integrating Bottom-Up and Top-Down Approaches.

Nuechterlein KH, Ventura J, Subotnik KL, Hayata JN, Medalia A, Bell MD.

Am J Psychiatr Rehabil. 2014 Jul;17(3):225-253.

5.

Transcriptional dysregulation of γ-aminobutyric acid transporter in parvalbumin-containing inhibitory neurons in the prefrontal cortex in schizophrenia.

Bitanihirwe BK, Woo TU.

Psychiatry Res. 2014 Dec 30;220(3):1155-9. doi: 10.1016/j.psychres.2014.09.016. Epub 2014 Oct 2.

6.

Perineuronal nets and schizophrenia: the importance of neuronal coatings.

Bitanihirwe BK, Woo TU.

Neurosci Biobehav Rev. 2014 Sep;45:85-99. doi: 10.1016/j.neubiorev.2014.03.018. Epub 2014 Apr 4. Review.

7.

Novel implications of Lingo-1 and its signaling partners in schizophrenia.

Fernandez-Enright F, Andrews JL, Newell KA, Pantelis C, Huang XF.

Transl Psychiatry. 2014 Jan 21;4:e348. doi: 10.1038/tp.2013.121.

8.

Altered language network activity in young people at familial high-risk for schizophrenia.

Thermenos HW, Whitfield-Gabrieli S, Seidman LJ, Kuperberg G, Juelich RJ, Divatia S, Riley C, Jabbar GA, Shenton ME, Kubicki M, Manschreck T, Keshavan MS, DeLisi LE.

Schizophr Res. 2013 Dec;151(1-3):229-37. doi: 10.1016/j.schres.2013.09.023. Epub 2013 Oct 28.

9.

Overlapping and distinct gray and white matter abnormalities in schizophrenia and bipolar I disorder.

Anderson D, Ardekani BA, Burdick KE, Robinson DG, John M, Malhotra AK, Szeszko PR.

Bipolar Disord. 2013 Sep;15(6):680-93. doi: 10.1111/bdi.12096. Epub 2013 Jun 25.

10.

Delayed white matter growth trajectory in young nonpsychotic siblings of patients with childhood-onset schizophrenia.

Gogtay N, Hua X, Stidd R, Boyle CP, Lee S, Weisinger B, Chavez A, Giedd JN, Clasen L, Toga AW, Rapoport JL, Thompson PM.

Arch Gen Psychiatry. 2012 Sep;69(9):875-84. doi: 10.1001/archgenpsychiatry.2011.2084.

11.

Ultrastructural alterations of myelinated fibers and oligodendrocytes in the prefrontal cortex in schizophrenia: a postmortem morphometric study.

Uranova NA, Vikhreva OV, Rachmanova VI, Orlovskaya DD.

Schizophr Res Treatment. 2011;2011:325789. doi: 10.1155/2011/325789. Epub 2011 Jun 28.

12.

Age-related increase in the number of oligodendrocytes is dysregulated in schizophrenia and mood disorders.

Vostrikov V, Uranova N.

Schizophr Res Treatment. 2011;2011:174689. doi: 10.1155/2011/174689. Epub 2011 Jul 3.

13.

Impact on intracortical myelination trajectory of long acting injection versus oral risperidone in first-episode schizophrenia.

Bartzokis G, Lu PH, Raven EP, Amar CP, Detore NR, Couvrette AJ, Mintz J, Ventura J, Casaus LR, Luo JS, Subotnik KL, Nuechterlein KH.

Schizophr Res. 2012 Sep;140(1-3):122-8. doi: 10.1016/j.schres.2012.06.036. Epub 2012 Jul 17.

14.

Oligodendrocyte genes, white matter tract integrity, and cognition in schizophrenia.

Voineskos AN, Felsky D, Kovacevic N, Tiwari AK, Zai C, Chakravarty MM, Lobaugh NJ, Shenton ME, Rajji TK, Miranda D, Pollock BG, Mulsant BH, McIntosh AR, Kennedy JL.

Cereb Cortex. 2013 Sep;23(9):2044-57. doi: 10.1093/cercor/bhs188. Epub 2012 Jul 6.

15.

Neurodevelopmental effects of insulin-like growth factor signaling.

O'Kusky J, Ye P.

Front Neuroendocrinol. 2012 Aug;33(3):230-51. doi: 10.1016/j.yfrne.2012.06.002. Epub 2012 Jun 16. Review.

16.

Long acting injection versus oral risperidone in first-episode schizophrenia: differential impact on white matter myelination trajectory.

Bartzokis G, Lu PH, Amar CP, Raven EP, Detore NR, Altshuler LL, Mintz J, Ventura J, Casaus LR, Luo JS, Subotnik KL, Nuechterlein KH.

Schizophr Res. 2011 Oct;132(1):35-41. doi: 10.1016/j.schres.2011.06.029. Epub 2011 Jul 20.

17.

Expression of mutant human DISC1 in mice supports abnormalities in differentiation of oligodendrocytes.

Katsel P, Tan W, Abazyan B, Davis KL, Ross C, Pletnikov MV, Haroutunian V.

Schizophr Res. 2011 Aug;130(1-3):238-49. doi: 10.1016/j.schres.2011.04.021. Epub 2011 May 24.

18.

Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia.

Ho BC, Andreasen NC, Ziebell S, Pierson R, Magnotta V.

Arch Gen Psychiatry. 2011 Feb;68(2):128-37. doi: 10.1001/archgenpsychiatry.2010.199.

19.

White matter volume abnormalities and associations with symptomatology in schizophrenia.

Makris N, Seidman LJ, Ahern T, Kennedy DN, Caviness VS, Tsuang MT, Goldstein JM.

Psychiatry Res. 2010 Jul 30;183(1):21-9. doi: 10.1016/j.pscychresns.2010.04.016. Epub 2010 Jun 9.

20.

Mapping gray matter development: implications for typical development and vulnerability to psychopathology.

Gogtay N, Thompson PM.

Brain Cogn. 2010 Feb;72(1):6-15. doi: 10.1016/j.bandc.2009.08.009. Epub 2009 Sep 30. Review.

Supplemental Content

Support Center